Palisade Bio raises $2.0M via registered direct offering and warrants

PALISADE BIO, INC.

3,646,690 shares at $0.55/share for gross proceeds of ~$2.0M.
Concurrent warrants to purchase 3,646,690 shares at $0.7105, exercisable in 6 months.
Closing expected on or about May 10, 2022, subject to customary conditions.
Net proceeds for working capital and development of lead candidate LB1148.
Ladenburg Thalmann acting as exclusive placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.